Question 1

What is the minimum effective plasma level and why does it matter for drug action?

Accepted Answer

The minimum effective plasma level (Cmin) is the lowest drug concentration required to produce a therapeutic effect. A drug begins acting once plasma concentration reaches Cmin and remains effective as long as concentration stays above this threshold. When concentration falls below Cmin, the drug no longer elicits a response, defining the end of the drug's duration of action.

Question 2

How does increasing a drug dose affect the onset and duration of action?

Accepted Answer

Increasing the dose allows the minimum effective plasma level to be achieved more rapidly, resulting in faster onset and prolonged duration of action. A larger dose maintains plasma concentration above Cmin for an extended period before elimination reduces it below the therapeutic threshold, extending the overall effect duration.

Question 3

What is the relationship between dose doubling and drug effect duration?

Accepted Answer

According to one-compartment kinetics, doubling the dose increases the effect duration by approximately one half-life. This linear relationship between log dose and duration of effect holds true as long as plasma concentration remains well above Cmin. Understanding the Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration helps predict how dose changes affect drug action time.

Question 4

Why is doubling the dose problematic for drugs with a narrow therapeutic index?

Accepted Answer

Drugs with a narrow therapeutic index have a small margin between effective and toxic doses. Doubling the dose to extend duration may cause plasma concentration to exceed safe levels, resulting in adverse effects. For these drugs, repeating the same dose when levels fall to Cmin provides a safer alternative that maintains efficacy with minimal toxicity risk.

Question 5

What factors determine how long a drug remains effective in the body?

Accepted Answer

Drug action duration depends on dose size, the drug removal rate, tissue binding, and route of administration. These factors collectively determine how quickly the minimum effective plasma level is achieved and how long plasma concentration remains above Cmin before elimination reduces it below the therapeutic threshold.

Question 6

How do redistribution and elimination processes affect drug duration?

Accepted Answer

Drug duration depends on redistribution to poorly perfused tissues and elimination processes. Redistribution moves drug from the site of action to storage tissues, reducing active plasma concentration. Elimination removes drug from the body entirely. Together, these processes determine the rate at which plasma concentration falls below Cmin, ending the drug's therapeutic effect.

Question 7

What dosing strategy optimizes drug therapy for narrow therapeutic index drugs?

Accepted Answer

For drugs with narrow therapeutic indices, administering the same dose when plasma concentration drops to Cmin results in a minimal increase in duration while maintaining safety. This approach avoids the toxicity risk of dose doubling and provides more predictable, controlled therapeutic outcomes compared to increasing dose size.

Farmakokinetik–Farmakodinamik İlişki: Doz–Etki İlişkisinin Süresi

Browse More Videos